Cargando…
Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study
INTRODUCTION: The human monoclonal antibody adalimumab is known to induce an anti-globulin response in some adalimumab-treated patients. Antibodies against adalimumab (AAA) are associated with non-response to treatment. Immunoglobulins, such as adalimumab, carry allotypes which represent slight diff...
Autores principales: | Bartelds, Geertje M, de Groot, Els, Nurmohamed, Michael T, Hart, Margreet HL, van Eede, Peter H, Wijbrandts, Carla A, Crusius, Jakob BA, Dijkmans, Ben AC, Tak, Paul Peter, Aarden, Lucien, Wolbink, Gerrit J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046534/ https://www.ncbi.nlm.nih.gov/pubmed/21187010 http://dx.doi.org/10.1186/ar3208 |
Ejemplares similares
-
The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
por: Krieckaert, Charlotte Louise Maria, et al.
Publicado: (2010) -
A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue
por: van Kuijk, A W R, et al.
Publicado: (2008) -
Are biologics more effective than classical disease-modifying antirheumatic drugs?
por: Nurmohamed, Michael T, et al.
Publicado: (2008) -
Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial
por: Wientjes, Maike H. M., et al.
Publicado: (2021) -
Role of immune recognition in latent allotype induction and clearance. Evidence for an allotypic network
Publicado: (1981)